Podcasts about colorectal

This week, we present an inspiring episode for anyone interested in the history, present, and future of prostate cancer care. In this Legends in Urology installment of the BackTable Urology Podcast, Dr. Gerald Andriole joins guest host Dr. Niraj Badhiwala to reflect on a career that has left a lasting impact on the field. --- SYNPOSIS Dr. Andriole shares personal stories from his upbringing in Northeastern Pennsylvania and his journey into medicine. He reflects on his expedited education through Penn State and Jefferson Medical College and his path to urology. He discusses his pivotal work in prostate cancer screening, including the influence of major trials like The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, and traces the evolution of surgical and diagnostic techniques. The conversation also touches on current innovations and the future of prostate cancer management, offering valuable advice for the next generation of urologists. --- TIMESTAMPS 00:00 - Introduction01:59 - From Childhood to Medical School06:48 - Discovering Urology16:52 - Pioneering Prostate Cancer Screening24:07 - The PLCO Study: Design and Challenges28:57 - Controversies and Criticisms in Prostate Cancer Screening33:29 - Evolving Practices in Prostate Cancer Management44:19 - Future of Prostate Cancer Treatment

On la connaît pour ses bienfaits sur les os, mais la vitamine D aurait aussi un rôle à jouer contre le cancer colorectal ... C'est le vrai ou faux de la semaine ! Tous les samedis, retrouvez Flavie Flament en compagnie de Jimmy Mohamed dans l'émission "Ça va beaucoup mieux", votre magazine santé et bien-être.Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Health New Zealand is outsourcing more elective operations to private facilities to ease strain on the system. The agency aims to deliver more than 10,500 additional elective procedures by the end of June, by partnering with private hospitals to expand surgical capacity. The target is within reach with more than 8,600 procedures complete since March. Christchurch colorectal and general surgeon Chris Wakeman told Mike Hosking that although he gets paid less to do public work, this is the future of healthcare. He says it's so much more efficient and you can do a lot more work. LISTEN ABOVE See omnystudio.com/listener for privacy information.

Colorectal surgeon Dr Ada Ng from Sydney Adventist Hospital joins John to discuss the importance of testing for bowel cancer, and the symptoms you should keep an eye out for. Listen to John Stanley live on air from 8pm Monday to Thursday on 2GB/4BCSee omnystudio.com/listener for privacy information.

Colorectal cancer is the fourth most common cancer in the U.S. and the second leading cause of cancer death, but what if you could defeat it before it ever has a chance?About one in every 24 people will develop colorectal cancer in their lifetime. And most of the time, your genes are not to blame. So what can you do to lower your risk? First, eat a healthy diet that includes lots of fruits, veggies and whole grains.New research suggests you may also want to up your calcium intake. Researchers found adding 300 milligrams of calcium each day — which is about the amount in a glass of milk — was associated with a 17% lower risk for colorectal cancer.Get regular screenings. Most major organizations suggest you should start at age 45, but not everyone does. Colonoscopies not only look for cancer, they also can help doctors remove precancerous polyps, preventing future cancer.Stop smoking and don't drink in excess. Scientists reported that drinking an additional 20 grams of alcohol daily was linked to a 15% higher risk for colorectal cancer. That's about the amount in a large glass of wine.It's never too soon start.The number of people who have died from colorectal cancer has steadily decreased since the mid 1980s.Experts say this is due to more screening and changing lifestyles.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

June 2, 2025 ~ Donald Trump pledges to raise tariffs on steel. Another Grand Prix weekend is in the books. Colorectal cancer is on the rise among young people. SCOTUS rules Trump can revoke legal status for 500,000 people. Antisemitic terrorist attack in Boulder Colorado and the day's biggest headlines.

In this candid episode, join our hosts as they tackle the critical topic of health, wellness, and burnout in surgery. Drawing from their own personal experiences, they share the practical strategies they use to maintain balance, build resilience, and foster joy both in and out of the operating room.   But this conversation goes beyond coping mechanisms. Our hosts dive deep into the root causes of stress in the surgical profession and explore what it means to proactively design healthier, happier workplaces. They discuss how shifting the focus from individual stress management to eliminating systemic stressors can lead to more sustainable change.

Colorectal cancer rates in adults over the age of 50 have been falling since the 1980s, but that's not the case for young adults. New research shows that colorectal cancer incidences and deaths are increasing in people under 50.If that trend continues, colorectal cancer is expected to become the leading cause of cancer-related deaths among young adults globally by 2030.Delaware Public Media's Kyle McKinnon sits down with Bayhealth colorectal surgeon Dr. Assar Rather to examine the rise in colorectal cancer for young people and how it's being addressed.

Appendiceal neoplasms present with peritoneal carcinomatosis and despite aggressive CRS/HIPEC, often recur and are chemotherapy resistant. In this Colorectal DSWG SSO sponsored podcast episode, we discuss an overview of the recent publication of "Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis with GNAS Mutations" by Dr. Lowy's research lab at UCSD. The authors treated 16 patients in this Phase 2 study of oral Palbociclib in recurrent appendiceal adenocarcinoma patients and identified excellent treatment and long-term response with 13/16 of patients treated having reduction in CEA and excellent survival (median FU of 17.6 months, OS not reached). Dr Lowy provides informative background, study details and discusses next steps for this novel treatment approach. A link to the paper in question is https://pubmed.ncbi.nlm.nih.gov/39413348/

March is National Colorectal Cancer Awareness Month. In this B-Side episode, we dive into everything you need to know about the disease.Colorectal cancer is the fourth leading cause of cancer-related deaths in the Philippines, with an estimated one in 1,800 Filipinos at risk each year. To help understand its symptoms, treatments, and prevention, Dr. Dave Rennel L. Sebollena, Vice President of the Philippine Society of Gastroenterology, joins the conversation.We also explore the financial and healthcare support available for patients with Dr. Israel Francis A. Pargas, Senior Vice President for the Health Finance Sector and Spokesperson of PhilHealth.Interview by Edg Adrian EvaAudio editing by Jayson Mariñas

This isn't your father's colonoscopy. Colorectal screening is entering a new era, with innovations that make the process easier, detection earlier and more accessible than ever. From a simple blood test that can detect signs of cancer to AI technology helping doctors catch polyps that might otherwise go unnoticed, today's tools are transforming the screening experience. Whether you're due for your first test or curious about your options, this conversation offers the insight you need to take charge of your colorectal health — with clarity, confidence and peace of mind.Host:Sandra PeeblesAward-Winning JournalistExperts:Victor Maciel, M.D., Colorectal Surgeon at Baptist HealthAriel Sims, M.D., Gastroenterologist at Gastro Health

The diagnosis of cancer is rising in young adults (

Send us a textMarch is Colorectal Cancer Awareness Month. Colorectal cancer is the fourth most commonly diagnosed cancer in the U.S. and the second leading cause of cancer deaths. Yet this cancer can be prevented with screening and is highly treatable when detected early. On this episode of our DocTalk podcast, we're discussing colon cancer with Dr. Walid Chalhoub, the Division Chief of Gastroenterology at MedStar Southern Maryland Hospital Center, and the Co-Director of Advanced Endoscopy at MedStar Georgetown University Hospital. Dr. Chalhoub discusses the difference between gastroenterology and advanced gastroenterology, and how getting a colonoscopy can save your life.For an interview with Dr. Walid Chalhoub, or for more information about this podcast, contact MedStar Georgetown University Hospital Manager Media Relations, Ryan.M.Miller2@Medstar.net.Learn more about Dr. Chalhoub. For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

On the Saturday March 22, 2025 episode of the Richard Crouse Show we meet Emily Diebert. She is a Science Fellow at the Gemini South Observatory in Chile, where she writes children’s books by day and works as an astronomer by night. Her debut novel is “Bea Mullins Takes a Shot,” a novel about a 7th grader who, after being forced to join her school's hockey team discovers unexpected friendships and a budding crush on the team captain. Then, it’s National Colorectal Cancer Awareness Month, a month-long campaign aims to educate Canadians about colorectal cancer and encourage screening. Colorectal cancer is the second leading cause of cancer deaths in Canada but can be effectively treated when detected early. To help me raise awareness is Dr. Peter Stotland, chief of surgery at North York General Hospital and the surgeon who did my colon resection when I was diagnosed with colon cancer twelve years ago.

Colorectal cancer can spread to the liver, and once it does, patients are often at the bottom of the list to receive a liver transplant. But Northwestern Medicine is now offering a new transplant option for select patients that involves splitting a deceased donor liver in two parts. Reset hears from the first patient to undergo this treatment, Barclay Missen, and one of the surgeons Dr. Zachary Dietch. For a full archive of Reset interviews, head over to wbez.org/reset.

In this episode of the Onc Now Podcast, host Jonathan Sackier is joined by Sebastian Stintzing, Head of Department of Medicine, Division of Hematology, Oncology, and Cancer Immunology, Charité - Universitäetsmedizin Berlin, Germany. They discuss the most promising developments in gastrointestinal oncology, with particular focus on the role of personalised medicine in metastatic colorectal cancer treatment.  Timestamps:    00:00 – Introduction  03:04 – Impactful developments in gastrointestinal oncology  08:53 – Issues with funding clinical trials  14:17 – Designing trials and the importance of patient advocacy   17:11 – Translational biomarker programs  19:58 – Treatment strategies for RAS wild-type tumours  22:28 – The FIRE-4.5 study on mutant metastatic colorectal cancer  29:50 – Genetic profiling and epigenomics  33:12 – Precision medicine and immune oncology in GI cancers  34:52 – Colorectal cancer in younger adults  34:54 – Raising awareness for early screening of GI cancers 

Colorectal cancer is one of the most preventable cancers—when caught early. Yet, screening rates remain too low, and cases in younger adults are rising at an alarming rate. Disparities in access to screening also put certain communities at higher risk, making awareness and early detection more critical than ever. In this episode, we're joined by Dr. Reezwana Chowdhury, a leading gastroenterologist at Johns Hopkins and Chair of the American College of Gastroenterology's (ACG) Public Relations Committee. She's also a dedicated advocate for improving awareness in the South Asian community through her work with the South Asian IBD Alliance (SAIA). We cover: Who should get screened and when The rise in early-onset colorectal cancer The connection between IBD and colorectal cancer risk How screening can save your life This episode is presented in collaboration with the American College of Gastroenterology's Patient Care Committee.  

Cette année, une campagne choc a été adoptée pour son titre : "Va ch..."

Colorectal cancer is the second leading cause of cancer deaths in the U.S. and, alarmingly, rates are rising in younger adults. On this 20-Minute Health Talk, Marc Greenwald, MD, discusses risk factors, symptoms, treatments and the importance of early screening. He also addresses common concerns about colonoscopy, from advances in prep to the lifesaving procedure itself, and helps listeners understand the importance of being proactive about their health.    About the expert Dr. Greenwald is chief of colorectal clinical services; surgeon-in-chief; and director of the rectal cancer program at North Shore University Hospital. About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth

On the Saturday March 22, 2025 episode of the Richard Crouse Show we meet Emily Diebert. She is a Science Fellow at the Gemini South Observatory in Chile, where she writes children's books by day and works as an astronomer by night. Her debut novel is “Bea Mullins Takes a Shot,” a novel about a 7th grader who, after being forced to join her school's hockey team discovers unexpected friendships and a budding crush on the team captain. Then, it's National Colorectal Cancer Awareness Month, a month-long campaign aims to educate Canadians about colorectal cancer and encourage screening. Colorectal cancer is the second leading cause of cancer deaths in Canada but can be effectively treated when detected early. To help me raise awareness is Dr. Peter Stotland, chief of surgery at North York General Hospital and the surgeon who did my colon resection when I was diagnosed with colon cancer twelve years ago.

I shared Charlee's journey with Hirschsprung's Disease on Tom's Hirschsprung's Podcast.Charlee has been having ongoing medical issues for a year and a half. We have seen multiple doctors and referred to GI Specialists who ran many tests and procedures but still could not determine the root cause. We were told by multiple doctors that it had nothing to do with her Hirschsprung's Disease. (She was diagnosed at 3 days old and had a life-saving surgery at 8 days old). After doing our own extensive research and finding a community of parents, caretakers, and people with the Disease we found the # 1 recommended  Hirschsprung's Disease doctor in the country, Dr. Wood and reached out to him. We had several phone calls with him and his team prior to our trip to Ohio and they were so knowledgeable and supportive. On September 11th, we traveled to Nationwide Children's Hospital in Columbus, Ohio to see Dr. Wood and the team at the Center for Colorectal and Pelvic Reconstruction (CCPR).  Charlee had an exam under anesthesia where Dr. Wood found that she is missing about 80% of the dentate line. We are grateful for our team at Nationwide and feel supported, finally. We are still processing what the next part of our journey looks like and we're trying to give ourselves grace along the way. To learn more about Charlee's journey, please check out an update video I shared here, www.instagram.com/robyn_lynne. I also plan to share about our experience staying at the Ronald McDonald House while in Ohio. I cannot say enough about how amazing they are. More updates to come! Our girl is so brave, and she will not be defeated.

Ecoutez Ca va beaucoup mieux avec Agathe Landais du 28 février 2025.

Episode 28: 'HAPPY BIRTHDAY HIVESCUM STEVE'Welcome Scummers to the 29th Broadcast From Sump City Radio! Today we celebrate not only the Launch of this episode, but also the Birthday of your host Hivescum Steve.So we asked "Mr Steve, At the ripe old age of 43 what wisdom do you have to share with us?" and after a moment of contemplation, he said the following"Three thing... One. Roll with the punches. For example if you put a project out later than you ideally wanted it to be released and it then happens to fall on a date of celebration, lean into it! make it seem like that was the plan all along!Two. If you start bleeding from places you should not be bleeding, go see a Rogue Doc! Trust me the sooner you do the better you'll be for it. I know it's not fun, but there's enough stuff trying to kill us in The Underhive, don't let your own body be one of them!And three.. I forget what Three was... but just be excellent to each other, the hives already got enough scum and villainy in it, we don't need to add to it.Oh Wait! No.. Three was this.. Believe in the things you enjoy doing! If you believe in it, it doesn't matter what anyone else thinks. You'll find people along the way who DO believe in it and those will be the important people."Wise words indeed.But other than the Sage wisdom of some old fart, we also have The Awesome WELLYWOOD WARGAMING Joining us for..well.. THE ENTIRE SHOW! (We are honoured indeed!)So you get to listen to Hivescum Steve, Underhiver Chris and Damon of Wellywood talking about everything from what they've been up to, what they've seen in the community that's cool and then talking about W.W. and the latest PDF update to VENATORS!Also We read out some letters from you scummers!Additionally we hear from NATOMI SCALTO not once but TWICE as she finally concluded her epic PUBTALE (and buckle in for that one folks, its 1 hour and 25 minutes long!)We also get some solid wisdom from Van Saar Agony Uncle KLAUS VONTHROB.The GOFUNDME set up by Carl Johnston IS STILL LIVE FOR A FEW DAYS! If you would like to help support Hivescum Steve and his family through his treatment and recovery from Colorectal cancer, you can donate here, and much love to you.https://gofund.me/8b37846aNeed a musician to help you with your projects? Go check out MURDER CYBORGS patreon page!⁠ ⁠⁠⁠⁠https://www.patreon.com/murder_cyborg⁠ ⁠⁠⁠ And Tik Tok:⁠ ⁠⁠⁠⁠https://www.tiktok.com/@murder_cyborg⁠⁠⁠⁠⁠ Need help with painting your miniatures? Then please consider ⁠⁠⁠⁠THE UNRELENTING BRUSH⁠⁠⁠ who do international commission painting services, tuition and painting workshops!⁠https://www.theunrelentingbrush.co.uk/⁠CHECK OUT OUR VERY ACTIVE⁠ ⁠⁠DISCORD COMMUNITY⁠⁠⁠!⁠https://discord.com/invite/mGuCwXNHYh⁠CHECK OUT ⁠OUR ⁠SPOTIFY PLAYLIST '⁠⁠Sump City Radio: The Music Hours⁠⁠'⁠⁠. So whether it's for something to listen to whilst playing a game or painting your models, we've got you covered.Almost ALL of the music we use in the show is made by ⁠⁠⁠⁠⁠http://teknoaxe.com⁠ ⁠⁠⁠ or ⁠⁠⁠⁠⁠https://whitebataudio.comTIME STAMPS00:00:00 - INTRO & WELCOME00:24:45 - NATOMI & SCROFULUS PYLE00:31:39 - HOT IN THE HIVE01:31:43 - KLAUS VON THROB, AGONY UNCLE01:39:02 - SHOOTING THE SHIT03:24:08 - PUBTALES, NATOMI'S PART 204:48:50 - YOUR LETTERS & OUTRO

BUFFALO, NY - February 18, 2025 – A new #researchpaper was #published in Oncotarget, Volume 16, on February 12, 2025, titled “Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen." In this study, researchers Doaa A. Gamal, Aiat Morsy, and Mervat Omar from Assiut University Hospital, evaluated a new maintenance treatment for metastatic colorectal cancer (mCRC). Their findings suggest that a combination of two drugs—Panitumumab, a targeted therapy that blocks a protein called epidermal growth factor receptor to slow cancer growth, and low-dose Capecitabine, a chemotherapy drug that converts into 5-fluorouracil (5-FU) inside the body to stop cancer cells from growing and dividing—could help extend survival in patients with mCRC. This regimen appears to be both effective and well-tolerated, especially for patients with wild-type KRAS mCRC who had previously responded to treatment. Colorectal cancer is one of the leading causes of cancer-related deaths worldwide. Standard treatment often involves a combination of chemotherapy and targeted therapies, but many patients face challenges related to treatment toxicity and resistance, which can lead to treatment interruptions. This study tested whether a lower-intensity maintenance treatment could help keep the cancer under control after initial treatment. The study involved 25 mCRC patients with wild-type KRAS and BRAF, who first received six rounds of standard 5-FU-based chemotherapy with Panitumumab. Patients who responded well then switched to a maintenance treatment of Panitumumab every two weeks and a low, continuous dose of Capecitabine. The results showed that patients had a median progression-free survival of 18 months and a median overall survival of 45 months, indicating a strong potential benefit. Patients with metastases detected at the same time as the primary tumor showed a longer progression-free survival than those with metastases appearing later. The treatment was also well tolerated, with only 8% of patients experiencing severe side effects such as skin rash or diarrhea, which were managed with standard treatments. "In our research, the toxicity profile was very acceptable, and no patients needed to stop treatment or had a dose modification due to toxicity." Finding a way to keep cancer under control while reducing side effects is a major goal in cancer treatment. While other maintenance therapies like Bevacizumab and Cetuximab have been studied, this research suggests that Panitumumab with low-dose Capecitabine could be a promising new option. Panitumumab is already an FDA-approved drug, but its role in maintenance therapy had not been extensively explored. The results of this study suggest that this combination may help delay disease progression while keeping side effects manageable, ultimately improving patients' quality of life. Although larger studies are needed, these findings open the door for further clinical trials to confirm the benefits of this regimen. If validated, this approach could change the standard of care for mCRC patients, particularly those who cannot tolerate more intensive chemotherapy. DOI - https://doi.org/10.18632/oncotarget.28687 Correspondence to - Doaa A. Gamal - doaaalygamaal@gmail.com Video short - https://www.youtube.com/watch?v=wuPSS0EdK-8 To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

February marks the start of 'Move Your Butt for Bowel Cancer' month - an awareness movement designed to encourage people to think about the condition. Colorectal cancer is the most commonly registered cancer in New Zealand, with thousands of cases diagnosed per year. Naturopath and wellness expert Erin O'Hara explains the importance of getting checked regularly - and eating a healthy diet to keep harmful effects at bay. LISTEN ABOVESee omnystudio.com/listener for privacy information.

À l'occasion de la journée mondiale contre cancer, une étude de la fondation ARC met en lumière les freins au dépistage du cancer colorectal. Voici quelles sont les principales résistances et comment les surmonter. Ecoutez Ça va Beaucoup Mieux avec Aline Perraudin du 04 février 2025.

BUFFALO, NY - January 27, 2025 – A new #research paper was #published in Oncotarget's Volume 16 on January 21, 2025, titled “Assessment of cfDNA release dynamics during colorectal cancer surgery." Researchers from the University of Brasília investigated how cell-free DNA (cfDNA) levels in the blood change before, during, and after colorectal cancer surgery. The study found that cfDNA levels increase significantly during and after surgery. The findings suggest that cfDNA could help clinicians evaluate surgery effectiveness and monitor patient outcomes. cfDNA consists of small DNA fragments released into the bloodstream when cells die and break apart. In healthy individuals, cfDNA usually comes from normal cell turnover, while in cancer patients, some of it originates from tumor cells. Measuring cfDNA levels offers valuable insights into a patient's condition and is already being used to track disease progression and treatment response in cancers such as lung, breast, and colorectal cancer. Colorectal cancer is one of the most common cancers worldwide, affecting millions of people each year. Surgery is often the primary treatment, but up to 50% of patients experience cancer recurrence afterward. In this study, the research team, led by first author Mailson Alves Lopes and corresponding author Fabio Pittella-Silva, analyzed blood samples from 30 patients at three key time points: before, during, and after surgery. It was found that cfDNA levels increased nearly threefold during surgery and doubled after surgery compared to pre-surgery levels. The increases were even higher in individuals over 60, those with preexisting conditions such as diabetes or heart disease, and patients with elevated levels of carcinoembryonic antigen (CEA), a common cancer marker. Patients with the highest cfDNA levels were those with larger or more aggressive tumors, likely due to greater tissue damage during surgery. Additionally, longer surgeries were linked to higher cfDNA levels. “[...]we observed that cfDNA concentration may rise in correlation with the duration of the surgery, highlighting its potential as a marker of surgical quality.” These findings suggest that cfDNA could be a valuable, non-invasive biomarker for clinicians to monitor colorectal cancer patients. Tracking cfDNA levels may help better evaluate surgical outcomes and determine whether patients require closer follow-up care. While these findings are promising, further research is needed to standardize cfDNA testing and validate its usefulness. Larger studies could help establish cfDNA testing as a reliable tool for cancer care and postoperative monitoring, with the potential to become a routine part of clinical practice in the future. DOI - https://doi.org/10.18632/oncotarget.28681 Correspondence to - Fabio Pittella-Silva - pittella@unb.br Video short - https://www.youtube.com/watch?v=jC5_xqIrbtA About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science). To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Download the FREE Colorectal Cancer Facts and Stats from Fight CRC! Colorectal cancer is becoming increasingly prevalent among individuals under 50. By 2030, it's expected to claim the most lives among this age group, with devastating implications. Currently, Colon cancer is the top cause of cancer death in men and the second in women, trailing only behind breast cancer. Today, we talk about the growing prevalence of colorectal cancer, urging you to take control of your health through lifestyle assessments, screenings, and proactive habits. At the end, we share three actionable steps to kickstart your journey toward better colon health. Our other video on this topic: https://www.youtube.com/watch?v=y9yYu0LOu7Y&t=0s BUY MARK'S BOOK! The Evolving Man: Life Virtues Men Don't Talk About https://bit.ly/TheEvolvingMan USEFUL FINANCIAL TOOLS https://geni.us/new_retirement Use this link for a FREE 14 Day Trial! [Get the FREE Downsizing Guide] How to prepare to downsize your home CHAPTERS: 00:00 Introduction 04:41 Excessive Consumption of Processed Meats 06:28 Not Physically Active 08:10 Smoking 10:56 Lack of Regular Screening 12:44 Review and Adjust Lifestyle Choices CONNECT: Engage in our Free Facebook Community Facebook: /retirementtransformed Instagram: @retirementtransformed LinkedIn: /retirementtransformed Amazon Shop: https://www.amazon.com/shop/retirementtransformed ABOUT RETIREMENT TRANSFORMED Husband and wife duo, Mark & Jody Rollins, inspire and serve as personal guides to meaningful, transformational journeys for individuals who are planning for, going through or are living in retirement. This is everything in retirement beyond your financial plan. We are not financial advisors or medical experts. Any advice we give is our own and should not be taken as professional advice. This video is for informational and entertainment purposes only. Please seek professional assistance before making any financial decisions or changes that can affect your physical or mental health. FTC: Some links mentioned above may be affiliate links, which means we earn a small commission if you buy a product from the specific link. This episode is not sponsored.

If hemorrhoids are causing you discomfort or pain, this episode is a must-listen! Colorectal surgeon Alison Tammany, MD, breaks down what hemorrhoids are, highlights the risk factors, and offers practical tips for relief. Don't let embarrassment stop you—take charge of your health and find the solutions you need.

Colorectal cancer is the fourth most common cancer in Canada, but screening doesn't begin until age 50. Seeing younger people getting diagnosed, Dr. Shady Ashamalla helped launch Sunnybrook's Young Adult Colorectal Cancer Centre in Toronto. It offers minimally invasive care to patients like Catherine Mifsud, diagnosed with three kids at home in the prime of her career.

In this episode of SurgOnc Today®, Dr. Sinziana Dumitra discusses the evaluation and management of patients with peritoneal metastases from MSI-high colorectal cancer with Dr. Joshua Leinwand and Dr. Zachary Brown, including the role of HIPEC, immunotherapy, and differences in clinical characteristics and outcomes compared with microsatellite-stable disease.

In this episode, Jonathan Sackier sits down with David Wan to discuss the latest advances in colorectal cancer screening, the importance of high-quality colonoscopy, and the emerging role of AI in polyp detection.    Timestamps:     (00:00)-Introduction  (01:45)-Linking neuroscience and gastroenterology  (05:16)-The role of the microbiome in disease (7:44)-Unusual clinical cases (13:52)-Colorectal cancer screening (21:47)-Virtual colonoscopy (23:03)-Faecal calprotectin (25:11)-How to ensure a high-quality colonoscopy? (30:36)-Inpatient gastrointestinal care (34:47)-Variceal bleeding (36:30)-New horizons in gastroenterology (39:53)-Wan's three wishes for healthcare

Colorectal cancer, the disease that claimed the life of "Black Panther" actor Chadwick Boseman at age 43, was once considered an “old person's” illness. It no longer is. The National Cancer Institute says early-onset colorectal cancer is now the No. 1 cause of cancer death in people 20 to 49 years old. It gets worse. Studies show that cancer that develops in younger people tends to be more aggressive. So, why are Gen Xers, millennials, and Gen Zers developing a disease they never would have dreamed of getting not that long ago? To help answer this question, I am so honored to be joined by Dr. Andrea Cercek, a board-certified medical oncologist who specializes in the treatment of patients with colorectal cancer (CRC) at Memorial Sloan-Kettering Cancer Center. Dr. Cercek is also the founder and co-director of the Center for Young Onset Colorectal and Gastrointestinal Cancer – this clinic – dedicated to serving the specific needs of people under 50 who have these cancers, is the first of its kind in the world. In this episode, I talk with Dr. Cercek about the possible causes for this rise in colorectal cancers, what we can do to reduce our risk of developing colorectal cancer, and about the exciting treatment options that are being developed at MSK to cure colorectal cancer without the often-crippling side effects of radiation, chemo, and surgery.  One of the beneficiaries of Dr. Cercek's research and treatment is her former patient, Kelly, who also join us in this conversation. Kelly was just 29 with an 8-month-old baby when she was-diagnosed with colorectal cancer. Thanks to the immunotherapy treatment that Dr. Cercek's team discovered, Kelly is now cancer-free, did not have to have chemo, radiation, or surgery, and has gone on to live a full and healthy life. To learn everything you need to know about colorectal cancer, and to hear one woman's inspiring story, this episode is for you! If you enjoy the show, please rate and review. Be sure to follow us on Instagram @TheInterviewWithLeslie. A new podcast is released every Wednesday.

Une nouvelle étude confirme que les produits laitiers, en particulier le lait et les yaourts, protègent du cancer colorectal. C'est l'un des cancers les plus fréquents en France. D'où l'importance de savoir comment le prévenir. Ecoutez Ça va Beaucoup Mieux avec Aline Perraudin du 13 janvier 2025.

Colorectal cancer is striking young adults at an alarming rate, with a surge in metastatic (Stage 4) cases that defies expectations. Why is this happening, and what can young adults do to protect themselves? In this urgent and eye-opening episode, Dr. Kimmie Ng, a world-renowned expert and Director of the Young-Onset Colorectal Cancer Center at Dana-Farber Cancer Institute, breaks down the latest research, the hidden risks driving this crisis, and the critical warning signs everyone should recognize. Discover actionable steps to reduce your risk, navigate treatment options, and advocate for early detection. Don't miss this essential conversation—it could save a life. This episode is brought to you by Takeda. For more information and resources check out the links below:  Young-Onset Colorectal Cancer Center at Dana-Farber Cancer Institute: https://www.dana-farber.org/cancer-care/treatment/gastrointestinal/programs/young-onset-colorectal-cancer   Clinical Trials and Research at Dana-Farber's Young-Onset Colorectal Cancer Center: https://www.dana-farber.org/cancer-care/treatment/gastrointestinal/programs/young-onset-colorectal-cancer/clinical-trials-research   Count Me In/Colorectal Cancer: https://joincountmein.org/colorectal   A Qualitative Study on Young-Onset Colorectal Cancer: https://blog.dana-farber.org/insight/2024/11/study-highlights-unique-needs-of-young-adults-with-colorectal-cancer/

Featuring perspectives from Dr Christopher Lieu, moderated by Dr Stephen “Fred” Divers CME information and select publications

Dr Christopher Lieu shares his perspectives on the evolving therapeutic landscape for patients with colorectal and gastroesophageal cancers, moderated by Dr Stephen "Fred" Divers. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/AON24).

Dr Christopher Lieu shares his perspectives on the evolving therapeutic landscape for patients with colorectal and gastroesophageal cancers.

Dr Christopher Lieu shares his perspectives on the evolving therapeutic landscape for patients with colorectal and gastroesophageal cancers.

Behind the Knife ABSITE 2025 – Up-to-date and high yield learning to help you DOMINATE the exam. Don't forget to check out our ABSITE Podcast Companion Book available on Amazon: https://www.amazon.com/Behind-Knife-ABSITE-Podcast-Companion/dp/B0CLDQWZG3/ref=monarch_sidesheet Be sure to check out our brand new free study aid, which includes all 32 review episodes, brief written summaries, high yield images, and flash cards. Simply create an account on our iOS or Android app or on our website and you will find the entire course in your Library. Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Google Play App Store: https://play.google.com/store/apps/details?id=com.btk.app Behind the Knife would like to sincerely thank Medtronic for sponsoring the entire 2025 ABSITE podcast series.  Medtronic has a rich history of supporting surgical education, and we couldn't be happier that they chose to partner with Behind the Knife.  Learn more at https://www.medtronic.com/en-us/index.html If you like the work that Behind the Knife is doing, please leave us a review wherever you listen to podcasts. Visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  

Behind the Knife ABSITE 2025 – Up-to-date and high yield learning to help you DOMINATE the exam. Don't forget to check out our ABSITE Podcast Companion Book available on Amazon: https://www.amazon.com/Behind-Knife-ABSITE-Podcast-Companion/dp/B0CLDQWZG3/ref=monarch_sidesheet Be sure to check out our brand new free study aid, which includes all 32 review episodes, brief written summaries, high yield images, and flash cards. Simply create an account on our iOS or Android app or on our website and you will find the entire course in your Library. Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Google Play App Store: https://play.google.com/store/apps/details?id=com.btk.app Behind the Knife would like to sincerely thank Medtronic for sponsoring the entire 2025 ABSITE podcast series.  Medtronic has a rich history of supporting surgical education, and we couldn't be happier that they chose to partner with Behind the Knife.  Learn more at https://www.medtronic.com/en-us/index.html If you like the work that Behind the Knife is doing, please leave us a review wherever you listen to podcasts. Visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  

Breakthroughs in the Treatment of Sickle Cell Disease with guest Dr. Cece Calhoun, December 1, 2024

Nobody really wants to talk about colorectal health but it's important, nonetheless. This episode is important to me, personally, after losing my mom to colon cancer 13 years ago. I'm joined by colorectal surgeon, Dr. Ritha Belizaire, to talk about not just what you can do to keep you insides healthy, but also how to advocate for yourself at the doctor (no matter what the issue), and how to make leaps of faith to start creating a life you love. Dr. Ritha Belizaire is a dual board certified general and colorectal surgeon and the owner of Houston Community Surgical, a solo private practice in the Houston Heights neighborhood. She is passionate about providing accessible and equitable surgical care to the Greater Houston community. She understands many colorectal related issues are sensitive or embarrassing for patients to discuss, even with their doctors. She aims to provide a safe and inclusive environment for patients to talk about all factors of their colorectal health to ensure the best outcomes for her patients. When she is not working in or on her practice, she loves to spend time with her two daughters, Amelia and Raffaela. LinkedIn - https://www.linkedin.com/in/rithabelizairemd FB -https://www.facebook.com/houstoncommunitysurgical IG - @rithabelizairemd TikTok - @rithabelizairemd Website - https://www.houstoncommunitysurgical.com Subscribe, rate, and review this podcast and get a copy of our Weekend Survival Guide as a thank you! Just email a screenshot of your review to admin@estheravant.com and we'll send it over ASAP! Thanks for your support! Get your Weight Loss That Lasts Cheat Sheet at: https://www.go.estheravant.com/cheatsheet Learn about our 12-week Gone For Good coaching program: www.estheravant.com/coaching Join the Live Diet-Free FB group: www.facebook.com/groups/livedietfree Connect with Esther on Instagram (shoot me a DM and let me know you listen to the podcast!): www.instagram.com/esther.avant

In this inaugural episode of the Surgical Oncology Insight series of SurgOnc Today®, Dr. Shishir Maithel, Editor of Surgical Oncology Insight, SSO's open-access journal, discusses with Dr. Brett Ecker the results of a systematic review and meta-analysis characterizing the incidence of cfDNA-positivity after resection of colorectal cancer liver metastases  with quantification of its sensitivity and specificity for postoperative recurrence, as reported in his article, "The Prognostic Role of Post-operative cfDNA after Resection of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis."

Drs. Benjamin Schlechter and Harshabad Singh explore the role and function of HER2 in gastrointestinal cancers, with a focus on gastroesophageal and colorectal cancers.

Doctors in recent years have noticed an alarming trend: Colorectal cancer rates among younger…

World-leading microbiome scientist and surgeon with over two decades of experience, Dr James Kinross, is on the podcast today talking about everything to do with the gut. Dark Matter is his first book and I highly recommend you check it out. http://dark-matter.org.uk/We talk about: Signs that your poop is unhealthySome of James favourite foods and nutrition strategies to improve the gutWhy we need to think like conservationists, and recognise that our guts are being radically altered and destroyed by our environmentWe also talk about functional gut disorders and why trauma, stress and childhood health are some of the first things James will ask about before ever reaching for a prescription pad, if at allWe talk about the estrobolome - the interaction of hormones and our microbesWhether our gut can dictate food choicesJames opinions on probiotics, gut health tests and their validityAs well as the relationship between our gut and brain health including ASD and dementiaDr James Kinross is a senior lecturer in colorectal surgery and consultant surgeon at Imperial College London and a visiting professor at the Royal College of Surgeons of Ireland. He leads a research team defining how the microbiome causes cancer and other chronic diseases of the gut.

Join for the fifth episode in the Association of Out Surgeons and Allies (AOSA) series for a comprehensive discussion of what the general surgeon needs to know prior to operating on a patient who has previously undergone gender affirming surgery. Host:  Dan Scheese, MD Andrew Schlussel, DO, Colorectal and General Surgeon, Charlie Norwood VA Medical Center Guests: Dr. Megan Lane (She/her) megalane@med.umich.edu Dr. Lane is a plastic surgery resident at the University of Michigan who is planning on going into Gender Affirming Surgery and general reconstruction. She completed a research fellowship in the National Clinician Scholars Program and focused primarily on patient-reported outcomes in gender affirming surgery. Dr. Amy Suwanabol pasuwan@med.umich.edu Dr. Suwanabol is a colorectal surgeon at the University of Michigan and the Ann Arbor VA. She assists the gender affirming surgeons at the University of Michigan in performing robotic-assisted vaginoplasty. Her research focuses on optimizing quality of life among surgical patients and their families, surgeon well-being, and cancer survivorship. Dr. Monica Llado-Farrulla lladorfar@ohsu.edu Dr. Llado-Farrulla was born and raised in Puerto-Rico, completed general surgery residency followed by plastic surgery residency at Tulane and Penn, respectively. She pursued a year of training in advanced gender surgery and is now currently at OHSU. Her practice largely focuses on facial feminization, chest affirming surgeries, phalloplasty, autologous breast reconstruction, and limb salvage.  Learn more and get involved with AOSA: https://www.outsurgeons.org Twitter/X: @OutSurgeons Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Today, we sit down with Dr. Leigh Erin Connealy, world-renowned medical doctor, leading functional integrative physician, and medical director of Cancer Center for Healing and Center for New Medicine. She uses conventional, homeopathic, Eastern, and modern medicine to address the root cause of medical maladies, including autoimmune disorders and cancer. What are some issues with conventional medicine and prescription drugs? Is it possible to heal cancer naturally? What steps can help prevent cancer? And why is colorectal cancer increasing among young people? Dr. Connealy answers all that and more on how to preserve your health. Get your tickets for Share the Arrows: https://www.sharethearrows.com/ --- Timecodes: (01:07) Dr Connealy's story (16:49) Problems with conventional medicine (22:22) How to lose weight  (32:10) Postpartum weight loss (35:44) Importance of sleep (39:07) Healing & preventing cancer (54:07) Body positivity movement (57:10) Colorectal cancer in young people (1:01:08) Hippocratic oath in medicine (1:05:38) How to find a good doctor --- Today's Sponsors: Seven Weeks Coffee — try Seven Weeks Coffee today at SevenWeeksCoffee.com and use the promo code: ALLIE to save 10% off your order. Covenant Eyes — protect you and your family from the things you shouldn't be looking at online. Go to coveyes.com/ALLIE to try it FREE for 30 days! Carly Jean Los Angeles — use promo code ALLIE50 for $50 off your order of $100+ at carlyjeanlosangeles.com. Birch Gold — protect your future with gold. Text 'ALLIE' to 989898 for a free, zero-obligation info kit on diversifying and protecting your savings with gold. --- Relevant Episodes: Ep 926 | The Secret Reason Doctors Push Cancer Drugs | Guest: Suzy Griswold https://podcasts.apple.com/us/podcast/ep-926-the-secret-reason-doctors-push-cancer-drugs/id1359249098?i=1000640353494 Ep 971 | Question Your Doctor, Save Your Life | Guest: Dr. Casey Means https://podcasts.apple.com/us/podcast/ep-971-doctors-are-paid-to-keep-us-sick-guest-dr-casey-means/id1359249098?i=1000649903503 Ep 693 | The Disturbing Truth About Breast Cancer Awareness Month | Guest: Chris Wark (Chris Beat Cancer) https://podcasts.apple.com/us/podcast/ep-693-the-disturbing-truth-about-breast-cancer/id1359249098?i=1000583065318 --- Buy Allie's book, You're Not Enough (& That's Okay): Escaping the Toxic Culture of Self-Love: https://alliebethstuckey.com/book Relatable merchandise – use promo code 'ALLIE10' for a discount: https://shop.blazemedia.com/collections/allie-stuckey Learn more about your ad choices. Visit megaphone.fm/adchoices